We detail a case of a 51-year-old woman with a background of estrogen receptor-positive invasive ductal carcinoma of the left breast, status post lumpectomy, neoadjuvant chemotherapy via right subclavian vein MediPort, and beam radiation. The gene discussed is ESR1; the disease is invasive ductal breast carcinoma.